Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2004 Publisher: Gebro Pharma GmbH, A-6391, Fieberbrunn, Austria
Seractil 400 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, oblong, both-sided scored film-coated tablet. |
Each film-coated tablet contains 400 mg of dexibuprofen.
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dexibuprofen |
Dexibuprofen is considered to be the pharmacologically active enantiomer of racemic ibuprofen. Racemic ibuprofen is a non-steroidal substance with antiinflammatory and analgesic effects. Its mechanism of action is thought to be due to inhibition of prostaglandin synthesis. |
| List of Excipients |
|---|
|
Tablet core: Hypromellose Film-coating material: Hypromellose |
10, 20, 30, 50, 60, 90, 100, 100x1 and 500x1 film-coated tablets in PVC/PVDC/aluminium blisters.
150 film-coated tablets in PE jars with dosing hole and hinged closure.
Not all pack sizes may be marketed.
Gebro Pharma GmbH, A-6391, Fieberbrunn, Austria
PL 04536/0007
31 October 2000
| Drug | Countries | |
|---|---|---|
| SERACTIL | Austria, Spain, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
